Monthly revenue of 160 TWSE-listed and TPEx (OTC) companies in Biotech & Medical, largest first. Industry total: NT$33.39 billion (+10.8% year on year).
| Rank | Company | Revenue | YoY | MoM |
|---|---|---|---|---|
| 1 | PEC | NT$2.84 billion | +102.0% | +7.6% |
| 2 | Lotus Pharm | NT$2.13 billion | -22.5% | -22.8% |
| 3 | Bora | NT$1.99 billion | +15.9% | -14.4% |
| 4 | Great Tree Pharmacy | NT$1.67 billion | +1.5% | +4.4% |
| 5 | EXCELSIOR | NT$1.02 billion | +38.6% | +6.4% |
| 6 | PEGAVISION | NT$793 million | +13.0% | +5.6% |
| 7 | Synmosa Biopharma | NT$766.6 million | +41.2% | +2.6% |
| 8 | Y.S.H. | NT$749.4 million | +4.4% | +13.7% |
| 9 | GKB | NT$748.3 million | -30.8% | +3.0% |
| 10 | Cenra Inc. | NT$746.3 million | +5.3% | +10.6% |
| 11 | TTY Biopharm | NT$727.8 million | +36.5% | -20.2% |
| 12 | MedFirst Healthcare Services | NT$697.7 million | +3.3% | +5.3% |
| 13 | ADIM | NT$634 million | +6.7% | +104.8% |
| 14 | S.C.P.C | NT$619 million | -3.5% | -11.5% |
| 15 | United Orthopedic | NT$555.6 million | +7.7% | +17.7% |
| 16 | VISCO | NT$527.8 million | +60.0% | +6.6% |
| 17 | Tci | NT$508.3 million | -19.4% | -2.4% |
| 18 | FRMSL | NT$497.9 million | +24.0% | +1.7% |
| 19 | BenQ Medical Technology | NT$444.2 million | +2.1% | +5.5% |
| 20 | TaiDoc | NT$439.9 million | +53.9% | +10.4% |
| 21 | Formosa Optical Technology | NT$430.6 million | +14.7% | +16.0% |
| 22 | Orient Europharma | NT$419.8 million | -4.2% | -3.6% |
| 23 | Hi-Clearance | NT$378.8 million | +1.4% | -8.7% |
| 24 | Universal Vision Biotechnology | NT$376.8 million | +8.7% | +4.9% |
| 25 | CHLITINA-KY | NT$370 million | +3.9% | -22.7% |
| 26 | ShareHope Medicine | NT$362.6 million | -5.9% | -15.3% |
| 27 | CHC | NT$346.2 million | +2.5% | -31.6% |
| 28 | Rossmax International | NT$342.3 million | +10.2% | +4.2% |
| 29 | VF | NT$334.7 million | -5.8% | -15.2% |
| 30 | Shiny Brands Group | NT$334.4 million | +12.3% | +19.0% |
| 31 | ACBT | NT$323 million | -2.0% | -12.1% |
| 32 | Norbel Baby | NT$315.5 million | +1.1% | +2.0% |
| 33 | SINPHAR | NT$295.9 million | +8.2% | +16.3% |
| 34 | We Can Medicines | NT$284 million | +4.5% | +6.6% |
| 35 | St.shine Optical | NT$281.4 million | -11.5% | -7.0% |
| 36 | EirGenix | NT$271.7 million | +287.9% | +131.5% |
| 37 | Intai Technology | NT$253.7 million | +49.0% | +6.5% |
| 38 | INCX | NT$240.3 million | +4.1% | -19.9% |
| 39 | Pacific Hospital Supply | NT$203.6 million | -6.3% | -7.3% |
| 40 | Bioteque | NT$200.9 million | +2.4% | +2.7% |
| 41 | NANG KUANG | NT$200.2 million | +6.6% | +23.5% |
| 42 | WELLELL | NT$198.2 million | -5.1% | -12.7% |
| 43 | Syngen Biotech | NT$193.4 million | +12.3% | -4.0% |
| 44 | SunMax Biotechnology | NT$190.3 million | +18.2% | -20.3% |
| 45 | Cowealth Medical Holding | NT$183.7 million | +12.5% | -46.9% |
| 46 | Arich Enterprise | NT$183 million | +68.1% | +2.4% |
| 47 | JDS | NT$180.9 million | -1.5% | -6.7% |
| 48 | Microbio | NT$169.6 million | -3.1% | +12.7% |
| 49 | TSH Biopharm | NT$168.9 million | +19.3% | -48.1% |
| 50 | SPT | NT$163.3 million | -47.4% | -47.2% |
| 51 | Maywufa | NT$162.9 million | +21.1% | +14.5% |
| 52 | PBF | NT$156.2 million | +16.7% | +13.9% |
| 53 | BIONIME | NT$154.1 million | +12.2% | -14.4% |
| 54 | OK BIOTECH | NT$153.3 million | +19.6% | -29.4% |
| 55 | Medigen Biotechnology | NT$151.5 million | +6.6% | -40.6% |
| 56 | Orient Pharma | NT$148 million | -1.3% | -0.5% |
| 57 | CVC Technologies | NT$145.3 million | +100.8% | +34.8% |
| 58 | Center Laboratories | NT$142.9 million | +6.1% | -17.7% |
| 59 | Savior Lifetec | NT$136.2 million | +21.3% | +30.8% |
| 60 | Vetnostrum | NT$134.8 million | +13.8% | +15.8% |
| 61 | ApexBio | NT$133.9 million | -13.9% | -3.9% |
| 62 | Dynamic Medical Technologies | NT$131.2 million | +12.3% | +2.2% |
| 63 | SCI | NT$131 million | +30.4% | -19.8% |
| 64 | Foresee Pharmaceuticals | NT$125.1 million | +397.5% | +1,895.4% |
| 65 | Medical Imaging | NT$120.6 million | +107.1% | +5.5% |
| 66 | Qing Song | NT$114.4 million | +17.0% | +3.1% |
| 67 | Chi Sheng Pharma & Biotech | NT$114.3 million | +2.2% | -2.9% |
| 68 | WeLeader Biomedical | NT$112.6 million | +15.3% | -3.4% |
| 69 | Ever Supreme Bio Technology | NT$112.1 million | +0.8% | +1.5% |
| 70 | ICARES Medicus | NT$105.5 million | +15.2% | -4.9% |
| 71 | Avita | NT$105.1 million | +61.5% | +4.3% |
| 72 | Syn-Tech Chen.&pharm | NT$101 million | -24.5% | -24.0% |
| 73 | Medigen Vaccine Biologics | NT$100 million | +43.2% | -51.7% |
| 74 | Crystalvue Medical | NT$98.7 million | +12.3% | +17.2% |
| 75 | Mycenax Biotech | NT$98 million | +41.0% | -15.8% |
| 76 | MA Kuang Healthcare Holding | NT$95.7 million | +7.3% | +6.0% |
| 77 | Dr.wu Skincare | NT$95.3 million | +30.0% | +36.1% |
| 78 | Excelsior Biopharma | NT$94.8 million | +32.6% | +24.1% |
| 79 | CCSB | NT$94.6 million | +598.5% | +36.9% |
| 80 | Bionet | NT$94.4 million | -12.0% | -2.7% |
| 81 | Tainet Communication System | NT$87.8 million | +21.0% | +16.5% |
| 82 | Mikobeaute International | NT$87.7 million | +57.7% | +23.4% |
| 83 | DIVA Laboratories | NT$85.7 million | +41.7% | +0.0% |
| 84 | KIM FOREST | NT$83.2 million | +40.3% | -0.5% |
| 85 | Onyx Healthcare | NT$82.9 million | -9.5% | -31.9% |
| 86 | A Plus Biotech | NT$81.1 million | +29.8% | +2.0% |
| 87 | LLF-KY | NT$78.3 million | +16.6% | +1.3% |
| 88 | SVBI | NT$78.3 million | +1.6% | +28.1% |
| 89 | MBI | NT$74.4 million | +17.3% | -15.6% |
| 90 | MiiS | NT$72.7 million | +6.7% | +7.5% |
| 91 | Easywell Biomedicals | NT$67.7 million | +128.2% | -51.1% |
| 92 | Handa Pharmaceuticals | NT$65.9 million | -24.8% | -6.5% |
| 93 | CHBIO | NT$62 million | -26.4% | -47.6% |
| 94 | TCM | NT$62 million | +10.2% | -0.6% |
| 95 | Delta Asia International | NT$53.8 million | -2.0% | -21.3% |
| 96 | Tanvex | NT$53.2 million | +13.7% | +67.1% |
| 97 | LI Kang Biomedical | NT$53 million | -8.1% | +26.4% |
| 98 | TaiMed Biologics | NT$52.4 million | +35.7% | -2.7% |
| 99 | Johnson Chemical Pharmaceutical Works | NT$50.1 million | -2.7% | +2.2% |
| 100 | Bioptik Technology | NT$48.1 million | -20.3% | +0.9% |
| 101 | Gga | NT$47.2 million | +3.3% | -2.0% |
| 102 | Level Biotechnology | NT$46.3 million | -8.2% | -27.4% |
| 103 | Tien Liang Biotech | NT$44.1 million | +2.3% | -22.6% |
| 104 | Genomics | NT$42.4 million | -12.8% | -56.7% |
| 105 | Jia Jie Biomedical | NT$42.1 million | +8.0% | -15.7% |
| 106 | KL | NT$41.4 million | +53.0% | -23.4% |
| 107 | Lagis Enterprise | NT$41.2 million | -3.3% | -6.0% |
| 108 | Yung Zip Chemical Ind | NT$40.1 million | +15.3% | +28.3% |
| 109 | Medeon Biodesign | NT$38 million | +2.7% | -83.6% |
| 110 | Sagittarius Life Science | NT$37.8 million | +125.2% | +5.8% |
| 111 | Ever Fortune. AI | NT$36.7 million | -1.0% | -0.7% |
| 112 | Applied BioCode | NT$35.8 million | +8.7% | -53.7% |
| 113 | GenMont | NT$35.4 million | -4.1% | -22.3% |
| 114 | Welgene Biotech | NT$33.9 million | +22.2% | -4.5% |
| 115 | StemCyte | NT$33 million | +16.0% | +7.6% |
| 116 | BONRAYBIO | NT$32.2 million | +30.1% | +7.3% |
| 117 | Abnova | NT$31.9 million | +19.1% | +30.8% |
| 118 | Sofiva Genomics | NT$30.2 million | -3.0% | -1.2% |
| 119 | Wiltrom | NT$29.7 million | +29.1% | +2.6% |
| 120 | EBM Technologies | NT$29.5 million | +184.8% | -6.0% |
| 121 | PharmaEngine | NT$22.5 million | -18.3% | -89.9% |
| 122 | Polylite Taiwan | NT$21.9 million | +0.6% | -2.0% |
| 123 | BioGend Therapeutics | NT$21.4 million | +24.8% | +0.0% |
| 124 | NeoCore Technology | NT$19.9 million | +34.9% | +20.3% |
| 125 | Health & Life | NT$19.5 million | -42.3% | -29.0% |
| 126 | BioLASCO Taiwan | NT$19.5 million | +6.7% | -8.4% |
| 127 | S&S Healthcare | NT$19.4 million | +26.3% | -8.7% |
| 128 | Shangya Technology | NT$17.8 million | +55.4% | +69.1% |
| 129 | PhytoHealth | NT$13.7 million | +6.0% | +15.3% |
| 130 | EPS Bio Technology | NT$12.6 million | -72.1% | -63.3% |
| 131 | Taiwan Biomaterial | NT$12.4 million | -34.1% | -27.4% |
| 132 | GlycoNex In | NT$11.9 million | — | — |
| 133 | G&E Herbal Biotechnology | NT$11.6 million | -50.7% | +1.4% |
| 134 | Oneness Biotech | NT$11.1 million | +154.7% | +97.2% |
| 135 | HeXun Biosciences | NT$10.6 million | -59.8% | -36.4% |
| 136 | Gongwin Biopharm Holdings | NT$9.3 million | +397.3% | +221.7% |
| 137 | aetherAI | NT$5.8 million | -88.1% | -34.6% |
| 138 | Taigen Biopharmaceuticals Holdings | NT$5.2 million | +60.2% | +66.6% |
| 139 | Horien Biochemical Technology | NT$4.7 million | -7.4% | -44.2% |
| 140 | OBI Pharma | NT$2.3 million | -58.7% | +40.8% |
| 141 | PELL BMT | NT$2.2 million | +3.2% | +15.2% |
| 142 | AmCad BioMed | NT$2.1 million | -16.6% | -6.3% |
| 143 | SynCore Biotechnology | NT$2 million | -0.3% | -0.4% |
| 144 | HNMC | NT$2 million | +42.2% | +78.9% |
| 145 | PG | NT$1.9 million | +894.8% | -69.9% |
| 146 | Pharmosa Biopharm | NT$1.6 million | — | -65.3% |
| 147 | BRIM | NT$1.5 million | +74.9% | +19.6% |
| 148 | UnicoCell | NT$1.3 million | -44.4% | -48.7% |
| 149 | NaviFUS | NT$564,000 | -19.0% | -30.8% |
| 150 | ENERGENESIS | NT$386,000 | -66.1% | -11.1% |
| 151 | Senhwa Biosciences | NT$80,000 | +0.0% | +0.0% |
| 152 | Lumosa Therapeutics | NT$78,000 | -54.9% | -63.0% |
| 153 | HCMED | NT$44,000 | -88.5% | -99.9% |
| 154 | TAHO Pharma | NT$10,000 | — | -99.2% |
| 155 | Intech Biopharm | NT$4,000 | -99.7% | -99.9% |
| 156 | Hanchor-KY | NT$0 | — | — |
| 157 | AP Biosciences | NT$0 | — | — |
| 158 | Caliway | NT$0 | — | — |
| 159 | FRMSP | NT$0 | — | — |
| 160 | Alar Pharmaceuticals | NT$0 | -100.0% | — |
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16